Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC : Primary and Correlative Biomarker Analyses
-
Owonikoko, Taofeek K. (Winship Cancer Institute of Emory University)
;
Niu, Huifeng (Millennium Pharmaceuticals. Inc.) ;
Nackaerts, Kristiaan (KU Leuven. Universitaire Ziekenhuizen) ;
Csoszi, Tibor (Hetenyi G Korhaz) ;
Ostoros, Gyula (Orszagos Koranyi TBC es Pulmonologiai Intezet) ;
Mark, Zsuzsanna (Tudogyogyintezet Torokbalint) ;
Baik, Christina (University of Washington Seattle Cancer Care Alliance) ;
Joy, Anil Abraham (University of Alberta. Cross Cancer Institute) ;
Chouaid, Christos (CHI de Créteil) ;
Jaime, Jesus Corral (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Kolek, Vitezslav (Fakultni Nemocnice Olomouc) ;
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Roubec, Jaromir (Fakultni Nemocnice Ostrava) ;
Santos, Edgardo S. (Lynn Cancer Institute/Boca Raton Regional Hospital) ;
Chiang, Anne C. (Yale University School of Medicine) ;
Speranza, Giovanna (Université de Sherbrooke) ;
Belani, Chandra P. (Penn State Cancer Institute) ;
Chiappori, Alberto (H. Lee Moffitt Cancer Center) ;
Patel, Manish R. (Florida Cancer Specialists/Sarah Cannon Research Institute) ;
Czebe, Krisztina (Tudogyogyintezet Torokbalint) ;
Byers, Lauren (Tudogyogyintezet Torokbalint) ;
Bahamon, Brittany (Millennium Pharmaceuticals. Inc.) ;
Li, Cong (Millennium Pharmaceuticals. Inc.) ;
Sheldon-Waniga, Emily (Millennium Pharmaceuticals. Inc.) ;
Kong, Eric F. (University of Texas M. D. Anderson Cancer Center) ;
Williams, Miguel (Millennium Pharmaceuticals. Inc.) ;
Badola, Sunita (Millennium Pharmaceuticals. Inc.) ;
Shin, Hyunjin (Millennium Pharmaceuticals. Inc.) ;
Bedford, Lisa (Millennium Pharmaceuticals. Inc.) ;
Ecsedy, Jeffrey A. (Millennium Pharmaceuticals. Inc.) ;
Bryant, Matthew (University of Texas M. D. Anderson Cancer Center) ;
Jones, Sian (University of Texas M. D. Anderson Cancer Center) ;
Simmons, John (University of Texas M. D. Anderson Cancer Center) ;
Leonard, E. Jane (Millennium Pharmaceuticals. Inc.) ;
Ullmann, Claudio Dansky (Millennium Pharmaceuticals. Inc.) ;
Spigel, David R. (Personal Genome Diagnostics) ;
Universitat Autònoma de Barcelona
guest ::
Subscribe to this discussion. You will then receive all new comments by email.
